His investigation of Theranos, Inc. raised serious doubts about claims by the firm and its celebrated 31-year-old founder, Elizabeth Holmes, that its new procedure for drawing and testing blood was a transformational medical breakthrough in wide use at the firm’s labs.
Carreyrou’s well-researched stories, reported in the face of threats of lawsuits and efforts to pressure some sources to back off of their accounts, led to a re-evaluation of Theranos’ prospects among investors and have been followed by regulatory actions against the company and widespread discussion that publications and institutions from Fortune and The New Yorker to Harvard and the White House may have been too quick to hail Holmes, a Stanford dropout whose personal wealth at the height of her startup’s rise was an estimated $4.5 billion, as a success story in the tradition of Steve Jobs, Bill Gates and Mark Zuckerberg.
To see all of the winners, go here.
Independent Association of Publishers’ Employees board authorized a strike vote to be conducted by its…
The Southern California News Group is seeking an assistant editor to help its jobs and…
Ian Krietzberg, a tech reporter for TheStreet.com, is leaving for a new opportunity. He has…
Timothy B. Lee writes in Asterisk magazine about why a lot of technology reporting is…
Megan Douglass has been named deputy social strategy editor at The Wall Street Journal. Douglass previously…
Business Insider's Louise Ridley is joining The Female Lead, the women's empowerment charity founded by Tesco Clubcard entrepreneur Edwina…